For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Velcade Dose Level 1 | BEAM + Rituxan + ATG(MUD pts only) + Velcade 1.0mg/m2 + ALLO SCT | 6 | None | 6 | 36 | 36 | 36 | View |
| Velcade Dose Level 2 | BEAM + Rituxan + ATG(MUD pts only) + Velcade 1.3mg/m2 + ALLO SCT | 2 | None | 2 | 3 | 3 | 3 | View |
| Gemcitabine Dose Level 3 | BEAM + Rituxan + ATG(MUD pts only) + Velcade 1.6mg/m2 + ALLO SCT | 0 | None | 0 | 0 | 0 | 0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dysrhythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCAE v3.0 | View |
| Decreased Cardiac Function | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCAE v3.0 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCAE v3.0 | View |
| Fluid Overload | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE v3.0 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE v3.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE v3.0 | View |
| Mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE v3.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE v3.0 | View |
| Elevated Creatinine | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCAE v3.0 | View |
| Hemorrhagic Cystitis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCAE v3.0 | View |
| Transaminitis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCAE v3.0 | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE v3.0 | View |
| Neutropenic Fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE v3.0 | View |
| SOB (Shortness of breath) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE v3.0 | View |
| Acute GvHD | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE v3.0 | View |
| Chronic GvHD | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE v3.0 | View |